XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statement of Cash Flows (Unaudited) - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:    
Net income $ (19) $ (30)
Adjustments to reconcile to net cash used in operating activities:    
Depreciation and amortization 22 23
Pension income (64) (63)
Change in fair value of the Preferred Stock and Convertible Notes embedded derivatives [1] (1) (3)
Net loss on sales of assets 0 1
Non-cash changes in workers' compensation reserves (13) (4)
Stock based compensation 4 6
Benefit from deferred income taxes (3) (1)
(Increase) decrease in trade receivables (7) 6
Increase in inventories (74) (38)
Increase in trade payables 5 33
Decrease in liabilities excluding borrowings and trade payables (26) (26)
Other items, net 8 3
Total adjustments (149) (63)
Net cash used in operating activities (130) (33)
Cash flows from investing activities:    
Additions to properties (19) (10)
Purchase of preferred equity interest (25) 0
Net proceeds from sales of assets 0 1
Net cash used in investing activities (44) (9)
Cash flows from financing activities:    
Net proceeds from Term Loan Credit Agreement 49 215
Net proceeds from Convertible Notes 0 25
Proceeds from sale of common stock 0 10
Debt issuance costs 0 (2)
Preferred stock cash dividend payments (3) (6)
Treasury stock purchases (1) (1)
Net cash provided by financing activities 45 240
Effect of exchange rate changes on cash, cash equivalents and restricted cash (14) (3)
Net (decrease) increase in cash, cash equivalents and restricted cash (143) 195
Cash, cash equivalents and restricted cash, beginning of period 423 256
Cash, cash equivalents and restricted cash, end of period 280 451
Series C Preferred Stock [Member]    
Cash flows from financing activities:    
Net proceeds from Series C Preferred Stock 0 99
Series A Preferred Stock [Member]    
Cash flows from financing activities:    
Repurchase of Series A Preferred Stock $ 0 $ (100)
[1] Refer to Note 19, “Financial Instruments”.